Heartflow PCI Navigator Heartflow PCI Navigator is the only integrated, AI-driven percutaneous coronary interventions ...
Coronary bifurcation lesions pose a significant challenge in interventional cardiology, accounting for approximately 15–25% ...
The Philippine Health Insurance Corporation (PhilHealth) has clarified that patients diagnosed with ischemic heart disease ...
Researchers have identified in a new study that the Triglyceride-Glucose (TyG) index and TyG-BMI (Triglyceride-Glucose-Body ...
Terumo Interventional Systems (TIS), a division of Terumo Corporation, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OPUSWAVE® Dual Sensor Imaging System. The ...
SNS Insider projects the U.S. Interventional Cardiology Devices Market to grow from USD 5.69 billion in 2024 to USD 9.38 billion by 2032, at a CAGR of 6.46%.Austin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ...
The next-generation version of Conavi’s Novasight Hybrid system was submitted to the U.S. Food and Drug Administration (FDA) for 510 (k) clearance in September 2025. Conavi’s first-generation version ...
TipRanks on MSN
Heartflow introduces Heartflow PCI Navigator
Heartflow (HTFL) introduced Heartflow PCI Navigator, the newest addition to the Heartflow One platform. PCI Navigator is the only integrated, ...
Terumo Interventional Systems announced today that it received FDA 510(k) clearance for its OpusWave dual-sensor imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback